These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 23588571)
21. Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele. Kajbafzadeh AM; Moosavi S; Tajik P; Arshadi H; Payabvash S; Salmasi AH; Akbari HR; Nejat F Urology; 2006 Nov; 68(5):1091-6; discussion 1096-7. PubMed ID: 17113899 [TBL] [Abstract][Full Text] [Related]
22. Women with voiding dysfunction secondary to bladder outlet dyssynergia in the setting of multiple sclerosis do not demonstrate significantly elevated intravesical pressures. Lemack GE; Frohman E; Ramnarayan P Urology; 2007 May; 69(5):893-7. PubMed ID: 17482929 [TBL] [Abstract][Full Text] [Related]
23. Does surgical release of secondary spinal cord tethering improve the prognosis of neurogenic bladder in children with myelomeningocele? Tarcan T; Onol FF; Ilker Y; Simsek F; Ozek M J Urol; 2006 Oct; 176(4 Pt 1):1601-6; discussion 1606. PubMed ID: 16952698 [TBL] [Abstract][Full Text] [Related]
24. Cross-sectional study of determinants of upper and lower urinary tract outcomes in adults with spinal dysraphism--new recommendations for urodynamic followup guidelines? Veenboer PW; Bosch JL; Rosier PF; Dik P; van Asbeck FW; de Jong TP; de Kort LM J Urol; 2014 Aug; 192(2):477-82. PubMed ID: 24603105 [TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions. Klaphajone J; Kitisomprayoonkul W; Sriplakit S Arch Phys Med Rehabil; 2005 Nov; 86(11):2114-8. PubMed ID: 16271557 [TBL] [Abstract][Full Text] [Related]
26. Which factors predict upper urinary tract deterioration in overactive neurogenic bladder dysfunction? Ozkan B; Demirkesen O; Durak H; Uygun N; Ismailoglu V; Cetinel B Urology; 2005 Jul; 66(1):99-104. PubMed ID: 15992868 [TBL] [Abstract][Full Text] [Related]
27. Ice-water test in the urodynamic evaluation of spinal cord injured patients. Chancellor MB; Lavelle J; Ozawa H; Jung SY; Watanabe T; Kumon H Tech Urol; 1998 Jun; 4(2):87-91. PubMed ID: 9623622 [TBL] [Abstract][Full Text] [Related]
28. Ileovesicostomy as an alternative form of bladder management in tetraplegic patients. Mutchnik SE; Hinson JL; Nickell KG; Boone TB Urology; 1997 Mar; 49(3):353-7. PubMed ID: 9123697 [TBL] [Abstract][Full Text] [Related]
29. Outcome in patients who underwent tethered cord release for occult spinal dysraphism. Guerra LA; Pike J; Milks J; Barrowman N; Leonard M J Urol; 2006 Oct; 176(4 Pt 2):1729-32. PubMed ID: 16945634 [TBL] [Abstract][Full Text] [Related]
30. [Urodynamic findings in patients with infantile cerebral palsy]. Bross S; Pomer S; Döderlein L; Knoll T; Michel MS; Staehler G; Gerner HJ; Alken P Aktuelle Urol; 2004 Feb; 35(1):54-7. PubMed ID: 14997416 [TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF; J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626 [TBL] [Abstract][Full Text] [Related]
32. Incontinent ileovesicostomy: Long-term outcomes and complications. Hellenthal NJ; Short SS; O'Connor RC; Eandi JA; Yap SA; Stone AR Neurourol Urodyn; 2009; 28(6):483-6. PubMed ID: 19274757 [TBL] [Abstract][Full Text] [Related]
33. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Reitz A; Stöhrer M; Kramer G; Del Popolo G; Chartier-Kastler E; Pannek J; Burgdörfer H; Göcking K; Madersbacher H; Schumacher S; Richter R; von Tobel J; Schurch B Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117 [TBL] [Abstract][Full Text] [Related]
34. Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: a pilot study. Krhut J; Samal V; Nemec D; Zvara P Spinal Cord; 2012 Dec; 50(12):904-7. PubMed ID: 22801191 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of clinico-urodynamic outcome of bladder dysfunction after surgery in children with spinal dysraphism - a prospective study. Kumar R; Singhal N; Gupta M; Kapoor R; Mahapatra AK Acta Neurochir (Wien); 2008 Feb; 150(2):129-37. PubMed ID: 18213439 [TBL] [Abstract][Full Text] [Related]
36. Intravesical vanilloids and neurogenic incontinence: ten years experience. Lazzeri M; Spinelli M; Zanollo A; Turini D Urol Int; 2004; 72(2):145-9. PubMed ID: 14963356 [TBL] [Abstract][Full Text] [Related]
37. Effect of pelvic floor interferential electrostimulation on urodynamic parameters and incontinency of children with myelomeningocele and detrusor overactivity. Kajbafzadeh AM; Sharifi-Rad L; Baradaran N; Nejat F Urology; 2009 Aug; 74(2):324-9. PubMed ID: 19476983 [TBL] [Abstract][Full Text] [Related]
38. A study on the feasibility of vesicomyotomy in patients with motor urge incontinence. ter Meulen PH; Heesakkers JP; Janknegt RA Eur Urol; 1997; 32(2):166-9. PubMed ID: 9286647 [TBL] [Abstract][Full Text] [Related]
39. [Significance of the examination position in urodynamic assessment of female urinary incontinence]. Grischke EM; Heinrich D; Auer L; Kubli F Geburtshilfe Frauenheilkd; 1987 Oct; 47(10):707-12. PubMed ID: 3678787 [TBL] [Abstract][Full Text] [Related]